Oragenics Inc. Common Stock (OGEN)

Oragenics Inc is a biotechnology company focused on the development of innovative solutions for infectious diseases and oral health

The company is primarily engaged in creating novel antibiotics and therapeutics, particularly against multi-drug resistant pathogens, as well as products aimed at enhancing oral health through advanced microbial therapies. Oragenics leverages its proprietary technologies and research capabilities to address significant medical needs, with a mission to improve patient outcomes and combat rising antibiotic resistance through targeted and effective treatment options.